Principles for the Technical Evaluation of β-Lactamase Inhibitor Antibiotic Compound Preparation

Home News Insights

Database

Laws & Regulations

Drug Catalog ChP Standards

Events

Webinars Offline Events

Services

Principles for the Technical Evaluation of β-Lactamase Inhibitor Antibiotic Compound Preparation

Local Title:β-内酰胺酶抑制剂抗生素复方制剂技术评价原则
Country/Region:Chinese Mainland
Competent Authority: Former China Food and Drug Administration (CFDA)
Type:Guideline
Status:In force
Release Date:2006-02-06
Implementation Date:2006-02-06

Request

Document

Language	Source	Title	Access
ZH	Official	β-内酰胺酶抑制剂抗生素复方制剂技术评价原则	Download

Summary

The Principles for the Technical Evaluation of β-Lactamase Inhibitor Antibiotic Compound Preparation was issued on Feb.6, 2006. it is formulated in order to strengthen the registration management of β-lactamase inhibitor antibiotic compound preparations and standardize the technical requirements for their registration.